| Product NDC: | 0093-1389 |
| Proprietary Name: | Cromolyn Sodium |
| Non Proprietary Name: | cromolyn sodium |
| Active Ingredient(s): | 40 mg/mL & nbsp; cromolyn sodium |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0093-1389 |
| Labeler Name: | Teva Pharmaceuticals USA Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074443 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19980526 |
| Package NDC: | 0093-1389-43 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (0093-1389-43) > 10 mL in 1 BOTTLE, DROPPER |
| NDC Code | 0093-1389-43 |
| Proprietary Name | Cromolyn Sodium |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (0093-1389-43) > 10 mL in 1 BOTTLE, DROPPER |
| Product NDC | 0093-1389 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cromolyn sodium |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19980526 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc. |
| Substance Name | CROMOLYN SODIUM |
| Strength Number | 40 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] |